Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US FDA's Brexit: One Staffer Moving, But Impact Still May Loom Large

Jan 09 2019

• By Derrick Gingery

Brexit effect and global business consequences concept with Union Jack, EU flag on balls and world map globe 3D illustration.

Related Content

New UK Drug Assessment Routes Among Latest Measures For No-Deal Brexit

Jan 04 2019

Jenkins' Retirement From US FDA Was Several Years In The Making

Dec 06 2016

US FDA Recognizes Eight EU Authorities, Triggers Mutual Recognition Provisions

Nov 01 2017

US FDA's China Staff Increase Takes Hold As Gottlieb Boosts Border Security

Aug 14 2017

FDA Posts OCI Agent In Singapore, But Other Foreign Offices Close

Jan 18 2016

FDA Encourages Pediatric Master Protocols With Bayesian Approach

Sep 27 2016

UK And EMA Could Work Together Informally After Brexit

Mar 15 2018

US FDA To Rely On Inspections From More European Countries

Dec 06 2018

US FDA’s Foreign Inspection Agenda: Visit The 1,000 Facilities It’s Never Seen

Jan 18 2017

UK Pharma Takes Hope From Draft Brexit Deal But Uncertainty Reigns

Nov 15 2018

No-Deal Brexit: UK Can Wave Goodbye To Savings From Parallel Imports

Nov 01 2018

Additional Topics

United Kingdom Europe United States Brexit FDA Regulation BioPharmaceutical Pink Sheet Perspectives

More from US FDA

More from Agency Leadership

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window